Dr. Jean-Paul Lellouche (1981 Ph.D. degree/education in Organic Chemistry field, University La Doua, Lyon - France) moved in October 2000 to the Bar-Ilan University (Ramat-Gan, Israel) - Department of Chemistry & Institute of Nanotechnology & Advanced Materials as a Full Professor in synthetic Organic Chemistry/Nano(bio)technology (July 2008) & recent Dpt Head (Oct 2017-July 2018). His main current R&D activities concern nanomaterials engineering science (magnetic/non-magnetic drug/siRNA & microRNA delivery systems, theranostic nanoparticles for human therapy). He authored 161 peer-reviewed scientific papers (2,528 citations), 16 patents, and 4 book chapters together with a quite recent start-up creation activity (January 2019 – NANODROPs project).
Current Research: innovative anti-leishmania nanoparticles and human therapy creams development, anti-bacterial silica-based nanoparticles & proteinous microspheres, mTHPC targeting using innovative magnetically active iron oxide-based nanoparticles, use of tungsten disulfide WS2 nanotubes for photothermal therapy and polymers reinforcement & bio-sensing activity, innovative developmental nanodiamonds surface engineering for use in a wide range of bio-activity applications, biocompatible nanoparticles for anti-diabetic bioactivity and human eyes defects full corrective actions
Innovative nanoparticles for MRI and innovative concept of theranostic imaging, anticancer therapy (PDT/PTT), drug delivery systems (gene silencing DNA/RNA delivery etc.) and antibacterial bioactivity
International Conference on Nanotechnology and Smart Materials (June 29-30, 2020 in Florence Italy
EuroSciCon Conference Meeting, June 4-6th, 2019 – Invited OCM member and speaker - (Paris – France)
11th World Congress on Neuropharmacology -Prices of esteemed support as OCM & phenomenal Keynote presentation), May 6-7th, 2019, Prague, Czech Republic.
Important subject since made relevant European projects with numerous European countries groups in several fields of research and industrial development
EDITORIAL BOARD MEMBER of (i) the “Journal of Nanomaterials & Molecular Nanotechnology” (OMICS Group Initiative),
(ii) “ARKIVOC” (Arkat USA, Inc.),
(iii) “Nanomedicine & Nanotechnology Journal” (Scientific Literature Company),
(iv) “Nanomedicine and Nanoscience Research” journal,
(v) “Non-Metallic Material Science Journal” (Bilingual Publishing Co) – Co-Editor (from 10.3.2019) & Editorial Board Membership activities,
(vi) MedCrave Journal of Analytic & Pharmaceutical Research - Editorial Board Membership